SCHEMBL31079231

SCHEMBL31079231

CCNC(=O)C(O)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.36
KCNH2 Q12809 1/20 0.36
BDKRB1 P46663 2/20 0.34
TSHR P16473 2/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
USP2 O75604 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
PKM P14618 1/20 0.33
KMT2A Q03164 1/20 0.32
EPHX1 P07099 1/20 0.31
MCL1 Q07820 1/20 0.31
FAAH O00519 1/20 0.30
POLB P06746 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9965559 0.79 PTGS1 (0.41) PTGS1KCNH2BDKRB1TSHRUSP2
SCHEMBL14111953 0.79 PTGS1 (0.41) PTGS1KCNH2BDKRB1TSHRUSP2
SCHEMBL25000269 0.77 CAPN1 (0.35) PTGS1KCNH2BDKRB1
SCHEMBL19864496 0.76 TSHR (0.35) TSHRHDAC4HDAC1HDAC6USP2
SCHEMBL12072459 0.76 TSHR (0.35) TSHRHDAC4HDAC1HDAC6USP2
SCHEMBL23095553 0.76 TSHR (0.35) TSHRHDAC4HDAC1HDAC6USP2
SCHEMBL19026679 0.76 TSHR (0.35) TSHRHDAC4HDAC1HDAC6USP2
SCHEMBL15597028 0.74 PTGS1 (0.65) PTGS1KCNH2TSHRUSP2MMP1
SCHEMBL26665913 0.73 MAPT (0.32) MMP1MMP3MMP9KMT2A
SCHEMBL2822675 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651872-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-11-26 EP disclosed
WO-2024155601-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS SEPTERNA, INC. (US) 2024-07-25 WO disclosed